Vaxart, Inc. (VXRT)
0.7375
+0.09
(+13.46%)
USD |
OTCM |
Jan 16, 12:15
Vaxart Market Cap: 177.04M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bionano Genomics, Inc. | 15.37M |
| AIM ImmunoTech, Inc. | 3.942M |
| Perspective Therapeutics, Inc. | 176.18M |
| Protalix Biotherapeutics, Inc. | 165.67M |
| Armata Pharmaceuticals, Inc. | 234.15M |
Market Cap Related Metrics
| PS Ratio | 1.136 |
| Price to Book Value | 6.617 |
| Price | 0.7375 |
| Earnings Yield | -30.13% |